chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Rash, Sleep disorder
Clinical narrative: rash on arm; fever (101); Nausea; I experienced new loss of smell; dizziness; really bad fogginess; unable to woke up in the morning; loss of taste sensation; Headache; chills; severe joint pain; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (I experienced new loss of smell), DIZZINESS (dizziness), FEELING ABNORMAL (really bad fogginess), SLEEP DISORDER (unable to woke up in the morning) and AGEUSIA (loss of taste sensation) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced ANOSMIA (I experienced new loss of smell), DIZZINESS (dizziness), FEELING ABNORMAL (really bad fogginess), SLEEP DISORDER (unable to woke up in the morning), AGEUSIA (loss of taste sensation), HEADACHE (Headache), CHILLS (chills), ARTHRALGIA (severe joint pain), FATIGUE (fatigue), PYREXIA (fever (101)) and NAUSEA (Nausea). On 18-Mar-2021, the patient experienced RASH (rash on arm). The patient was treated with PARACETAMOL (TYLENOL) for Paracetamol, at an unspecified dose and frequency. On 17-Mar-2021, ANOSMIA (I experienced new loss of smell), FEELING ABNORMAL (really bad fogginess), SLEEP DISORDER (unable to woke up in the morning), AGEUSIA (loss of taste sensation), HEADACHE (Headache), CHILLS (chills), ARTHRALGIA (severe joint pain), FATIGUE (fatigue) and PYREXIA (fever (101)) had resolved. At the time of the report, DIZZINESS (dizziness) and NAUSEA (Nausea) had not resolved and RASH (rash on arm) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable. Treatment included Tylenol
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Vaccination site bruising, Vaccination site discomfort, Vaccination site mass
Clinical narrative: red spot the size of a quarter at the injection site; hardness at the injection site; a minor lump at the injection site; injection site itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (red spot the size of a quarter at the injection site), VACCINATION SITE DISCOMFORT (hardness at the injection site), VACCINATION SITE MASS (a minor lump at the injection site) and INJECTION SITE PRURITUS (injection site itching) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A01A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced VACCINATION SITE BRUISING (red spot the size of a quarter at the injection site), VACCINATION SITE DISCOMFORT (hardness at the injection site), VACCINATION SITE MASS (a minor lump at the injection site) and INJECTION SITE PRURITUS (injection site itching). At the time of the report, VACCINATION SITE BRUISING (red spot the size of a quarter at the injection site), VACCINATION SITE DISCOMFORT (hardness at the injection site), VACCINATION SITE MASS (a minor lump at the injection site) and INJECTION SITE PRURITUS (injection site itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021: NNI
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction, Body temperature, Fatigue, Illness, Pyrexia
Clinical narrative: Delayed adverse events; Not feeling well; Fever of 102degrees; Felt tired; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Delayed adverse events), ILLNESS (Not feeling well), PYREXIA (Fever of 102degrees) and FATIGUE (Felt tired) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, the patient experienced ADVERSE REACTION (Delayed adverse events), ILLNESS (Not feeling well), PYREXIA (Fever of 102degrees) and FATIGUE (Felt tired). On 16-Mar-2021, ADVERSE REACTION (Delayed adverse events), ILLNESS (Not feeling well), PYREXIA (Fever of 102degrees) and FATIGUE (Felt tired) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Mar-2021, Body temperature: 102 (High) 102 degree.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD21-059464 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Mouth ulceration
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of MOUTH ULCERATION (developed ulcers in her mouth) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. No Medical History information was reported. On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced MOUTH ULCERATION (developed ulcers in her mouth). At the time of the report, MOUTH ULCERATION (developed ulcers in her mouth) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medications were not provided. Treatment for the included Benadryl and a swishing solution.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This spontaneous case was reported by a physician and describes the occurrence of HEADACHE (Headache) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Mar-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Heart rate, Hypertension, Palpitations
Clinical narrative: fast heartbeat; high blood pressure; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (fast heartbeat) and HYPERTENSION (high blood pressure) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced PALPITATIONS (fast heartbeat) and HYPERTENSION (high blood pressure). On 11-Mar-2021, PALPITATIONS (fast heartbeat) and HYPERTENSION (high blood pressure) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Mar-2021, Blood pressure measurement: high (High) High. On 11-Mar-2021, Heart rate: fast (High) Fast.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant and treatment information not provided
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Vomiting
Clinical narrative: headache; Nausea; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), NAUSEA (Nausea) and VOMITING (Vomiting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced HEADACHE (headache), NAUSEA (Nausea) and VOMITING (Vomiting). On 05-Mar-2021, HEADACHE (headache), NAUSEA (Nausea) and VOMITING (Vomiting) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment information not provided
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Abdominal pain upper, Flatulence, Muscle spasms
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (abdominal pain), MUSCLE SPASMS (cramping), FLATULENCE (gas) and ABDOMINAL PAIN UPPER (stomach ache) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010821A) for COVID-19 vaccination. No Medical History information was reported. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced ABDOMINAL PAIN (abdominal pain), MUSCLE SPASMS (cramping), FLATULENCE (gas) and ABDOMINAL PAIN UPPER (stomach ache). At the time of the report, ABDOMINAL PAIN (abdominal pain), MUSCLE SPASMS (cramping), FLATULENCE (gas) and ABDOMINAL PAIN UPPER (stomach ache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided. This case was linked to MOD-2021-116440.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Warm to touch at the injection site; Hard spot at the injection site; Slight itching at the injection site; Red spot at the injection site; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Mar-2021 and was forwarded to Moderna on 22-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to touch at the injection site), VACCINATION SITE INDURATION (Hard spot at the injection site), VACCINATION SITE PRURITUS (Slight itching at the injection site) and VACCINATION SITE ERYTHEMA (Red spot at the injection site) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warm to touch at the injection site), VACCINATION SITE INDURATION (Hard spot at the injection site), VACCINATION SITE PRURITUS (Slight itching at the injection site) and VACCINATION SITE ERYTHEMA (Red spot at the injection site). At the time of the report, VACCINATION SITE WARMTH (Warm to touch at the injection site), VACCINATION SITE INDURATION (Hard spot at the injection site), VACCINATION SITE PRURITUS (Slight itching at the injection site) and VACCINATION SITE ERYTHEMA (Red spot at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided Treatment information was not provided
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Rotator cuff syndrome
Clinical narrative: Impingement syndrome of the left shoulder; This spontaneous case was reported by a consumer and describes the occurrence of ROTATOR CUFF SYNDROME (Impingement syndrome of the left shoulder) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A2/Z1A and 007M(2/Z)0A) for COVID-19 vaccination.     Concomitant products included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (TDAP) from 21-Mar-2021 to 21-Mar-2021 for an unknown indication.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ROTATOR CUFF SYNDROME (Impingement syndrome of the left shoulder). At the time of the report, ROTATOR CUFF SYNDROME (Impingement syndrome of the left shoulder) outcome was unknown.            Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jun-2021: Follow up information received updated event information.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass, Vaccination site pain
Clinical narrative: Tennis ball sized lump (not circular) at the injection site; Sore to touch at the injection site; Red at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Tennis ball sized lump (not circular) at the injection site), VACCINATION SITE PAIN (Sore to touch at the injection site) and VACCINATION SITE ERYTHEMA (Red at the injection site) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced VACCINATION SITE MASS (Tennis ball sized lump (not circular) at the injection site), VACCINATION SITE PAIN (Sore to touch at the injection site) and VACCINATION SITE ERYTHEMA (Red at the injection site). At the time of the report, VACCINATION SITE MASS (Tennis ball sized lump (not circular) at the injection site), VACCINATION SITE PAIN (Sore to touch at the injection site) and VACCINATION SITE ERYTHEMA (Red at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product information was not provided. Treatment information was not provided.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site rash
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on her both arms and both legs) and VACCINATION SITE RASH (Rash at injection site) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, the patient experienced VACCINATION SITE RASH (Rash at injection site). On 10-Mar-2021, the patient experienced RASH (Rash on her both arms and both legs). On 01-Mar-2021, VACCINATION SITE RASH (Rash at injection site) had resolved. At the time of the report, RASH (Rash on her both arms and both legs) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications were reported. Treatment information was unknown.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Updated action taken, re-challenge .
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Anxiety, Dyskinesia, Headache, Migraine
Clinical narrative: Gastrointestinal issues; Anxiety; Face movements; Nose tingling on the left side; Mouth tingling on the left side; He feels like his muscles move on the inside; Migraine; Vomiting; Nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Gastrointestinal issues), ANXIETY (Anxiety), DYSKINESIA (Face movements), PARAESTHESIA (Nose tingling on the left side) and PARAESTHESIA ORAL (Mouth tingling on the left side) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included NAPHAZOLINE HYDROCHLORIDE (EYE DROPS [NAPHAZOLINE HYDROCHLORIDE]) for Glaucoma, LEVOTHYROXINE for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (Gastrointestinal issues), ANXIETY (Anxiety), DYSKINESIA (Face movements), PARAESTHESIA (Nose tingling on the left side), PARAESTHESIA ORAL (Mouth tingling on the left side), MUSCLE DISCOMFORT (He feels like his muscles move on the inside), MIGRAINE (Migraine), VOMITING (Vomiting), NAUSEA (Nausea) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, ABDOMINAL DISCOMFORT (Gastrointestinal issues), ANXIETY (Anxiety), DYSKINESIA (Face movements), PARAESTHESIA (Nose tingling on the left side), PARAESTHESIA ORAL (Mouth tingling on the left side), MUSCLE DISCOMFORT (He feels like his muscles move on the inside), MIGRAINE (Migraine), VOMITING (Vomiting), NAUSEA (Nausea) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Went to ER and was treated for migraine and GI with injections and also Tylenol
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Muscle discomfort, Nausea, Paraesthesia, Paraesthesia oral, Vomiting
Clinical narrative: Gastrointestinal issues; Anxiety; Face movements; Nose tingling on the left side; Mouth tingling on the left side; He feels like his muscles move on the inside; Migraine; Vomiting; Nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Gastrointestinal issues), ANXIETY (Anxiety), DYSKINESIA (Face movements), PARAESTHESIA (Nose tingling on the left side) and PARAESTHESIA ORAL (Mouth tingling on the left side) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included NAPHAZOLINE HYDROCHLORIDE (EYE DROPS [NAPHAZOLINE HYDROCHLORIDE]) for Glaucoma, LEVOTHYROXINE for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (Gastrointestinal issues), ANXIETY (Anxiety), DYSKINESIA (Face movements), PARAESTHESIA (Nose tingling on the left side), PARAESTHESIA ORAL (Mouth tingling on the left side), MUSCLE DISCOMFORT (He feels like his muscles move on the inside), MIGRAINE (Migraine), VOMITING (Vomiting), NAUSEA (Nausea) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, ABDOMINAL DISCOMFORT (Gastrointestinal issues), ANXIETY (Anxiety), DYSKINESIA (Face movements), PARAESTHESIA (Nose tingling on the left side), PARAESTHESIA ORAL (Mouth tingling on the left side), MUSCLE DISCOMFORT (He feels like his muscles move on the inside), MIGRAINE (Migraine), VOMITING (Vomiting), NAUSEA (Nausea) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Went to ER and was treated for migraine and GI with injections and also Tylenol
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue, Headache, Nausea, Pain in extremity
Clinical narrative: Loss of appetite; arm pain; Fatigue; Nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Loss of appetite), PAIN IN EXTREMITY (arm pain), FATIGUE (Fatigue), NAUSEA (Nausea) and HEADACHE (Headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     Concomitant products included DILTIAZEM, ESCITALOPRAM, ATORVASTATIN, CHONDROITIN SULFATE SODIUM, GLUCOSAMINE SULFATE POTASSIUM CHLORIDE (GLUCOSAMINE + CHONDROITIN [CHONDROITIN SULFATE SODIUM;GLUCOSAMINE SULFATE POTASSIUM CHLORIDE]), CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]), VITAMIN C [ASCORBIC ACID] and FISH OIL.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced DECREASED APPETITE (Loss of appetite), PAIN IN EXTREMITY (arm pain), FATIGUE (Fatigue), NAUSEA (Nausea) and HEADACHE (Headache). On 09-Mar-2021, PAIN IN EXTREMITY (arm pain) had resolved. At the time of the report, DECREASED APPETITE (Loss of appetite), FATIGUE (Fatigue), NAUSEA (Nausea) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       treatment information not provided.
Sex: F
Vaccine: COVID19
Symptoms: Allergy to vaccine, Feeling abnormal, Paraesthesia oral, Vaccination complication
Clinical narrative: lips started tingling; general not feeling; feeling funny; having allergic reaction or side effect; This spontaneous case was reported by a physician and describes the occurrence of PARAESTHESIA ORAL (lips started tingling), VACCINATION COMPLICATION (general not feeling), FEELING ABNORMAL (feeling funny) and ALLERGY TO VACCINE (having allergic reaction or side effect) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 ml. On 20-Mar-2021, the patient experienced PARAESTHESIA ORAL (lips started tingling) and VACCINATION COMPLICATION (general not feeling). 20-Mar-2021, the patient experienced FEELING ABNORMAL (feeling funny) and ALLERGY TO VACCINE (having allergic reaction or side effect). At the time of the report, PARAESTHESIA ORAL (lips started tingling) and VACCINATION COMPLICATION (general not feeling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: pain in the arm; little headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in the arm) and HEADACHE (little headache) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Heart attack. Concurrent medical conditions included Diabetes.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in the arm) and HEADACHE (little headache). At the time of the report, PAIN IN EXTREMITY (pain in the arm) and HEADACHE (little headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included medications for concurrent conditions. No treatment information provided.    This case was linked to MOD-2021-053091.
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Have not received the vaccine in the 42 days window) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Have not received the vaccine in the 42 days window). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Have not received the vaccine in the 42 days window) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: Follow-up received on 07-Jun-2021 included no new information.; Sender's Comments: This report refers to a case of Inappropriate Schedule Of Product Administration for mRNA-1273 (Lot number: Not provided) with no associated AEs.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of fatigue (felt very fatigued) and chills in a male patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced fatigue (felt very fatigued) and chills. At the time of the report, fatigue (felt very fatigued) and chills: resolving. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No relevant concomitant medications or treatment information reported. Reporter did not allow further contact.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Vaccination site pain
Clinical narrative: doesn't hurt but can feel it; large pink area/feeling like a pressure; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (doesn't hurt but can feel it) and VACCINATION SITE PAIN (large pink area/feeling like a pressure) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced FEELING ABNORMAL (doesn't hurt but can feel it) and VACCINATION SITE PAIN (large pink area/feeling like a pressure). At the time of the report, FEELING ABNORMAL (doesn't hurt but can feel it) and VACCINATION SITE PAIN (large pink area/feeling like a pressure) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Treatment information was not provided.    Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021: Follow-up information received on 09-MAY-2021 contains no new information.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Diarrhoea, Fatigue, Headache
Clinical narrative: Tired; vey bad headaches; body aches; uncontrollable diarrhea which lasted for 3 days; fever 102; joint pain; nausea; chills; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (uncontrollable diarrhea which lasted for 3 days), PYREXIA (fever 102), MYALGIA (body aches), FATIGUE (Tired) and HEADACHE (vey bad headaches) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to antibiotic (allergy to Augmentin lead to liver failure.) and Liver failure.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced MYALGIA (body aches). On 02-Mar-2021, the patient experienced HEADACHE (vey bad headaches). On an unknown date, the patient experienced DIARRHOEA (uncontrollable diarrhea which lasted for 3 days), PYREXIA (fever 102), FATIGUE (Tired), ARTHRALGIA (joint pain), NAUSEA (nausea) and CHILLS (chills). On 22-Mar-2021, PYREXIA (fever 102), MYALGIA (body aches), FATIGUE (Tired), HEADACHE (vey bad headaches), ARTHRALGIA (joint pain), NAUSEA (nausea) and CHILLS (chills) had resolved. At the time of the report, DIARRHOEA (uncontrollable diarrhea which lasted for 3 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.No treatment details were provided.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia
Clinical narrative: Tired; vey bad headaches; body aches; uncontrollable diarrhea which lasted for 3 days; fever 102; joint pain; nausea; chills; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (uncontrollable diarrhea which lasted for 3 days), PYREXIA (fever 102), MYALGIA (body aches), FATIGUE (Tired) and HEADACHE (vey bad headaches) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to antibiotic (allergy to Augmentin lead to liver failure.) and Liver failure.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced MYALGIA (body aches). On 02-Mar-2021, the patient experienced HEADACHE (vey bad headaches). On an unknown date, the patient experienced DIARRHOEA (uncontrollable diarrhea which lasted for 3 days), PYREXIA (fever 102), FATIGUE (Tired), ARTHRALGIA (joint pain), NAUSEA (nausea) and CHILLS (chills). On 22-Mar-2021, PYREXIA (fever 102), MYALGIA (body aches), FATIGUE (Tired), HEADACHE (vey bad headaches), ARTHRALGIA (joint pain), NAUSEA (nausea) and CHILLS (chills) had resolved. At the time of the report, DIARRHOEA (uncontrollable diarrhea which lasted for 3 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.No treatment details were provided.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Body temperature, COVID-19, Fatigue, Headache
Clinical narrative: patient got COVID after getting the vaccine; loss of taste and smell; sore throat; body aches; headaches; fever of 102 F; fatigue; really really stuffy nose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (patient got COVID after getting the vaccine), AGEUSIA (loss of taste and smell), OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (really really stuffy nose) and PAIN (body aches) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced NASAL CONGESTION (really really stuffy nose) and FATIGUE (fatigue). On 14-Mar-2021, the patient experienced COVID-19 (patient got COVID after getting the vaccine), AGEUSIA (loss of taste and smell), OROPHARYNGEAL PAIN (sore throat), PAIN (body aches), HEADACHE (headaches) and PYREXIA (fever of 102 F). The patient was treated with DOXYCYCLINE at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at a dose of 1 UNK; PSEUDOEPHEDRINE HYDROCHLORIDE (PSEUDAFED) at an unspecified dose and frequency; FIBRONECTIN at an unspecified dose and frequency; GUAIFENESIN (MUCINEX) at an unspecified dose and frequency; ASCORBIC ACID (VITAMINS C) at an unspecified dose and frequency; VITAMIN D [VITAMIN D NOS] at an unspecified dose and frequency and ZINC at an unspecified dose and frequency. At the time of the report, COVID-19 (patient got COVID after getting the vaccine), AGEUSIA (loss of taste and smell), OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (really really stuffy nose), PAIN (body aches), HEADACHE (headaches), PYREXIA (fever of 102 F) and FATIGUE (fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Mar-2021, Body temperature: 102 (High) Fever of 102 F. On 14-Mar-2021, SARS-CoV-2 test: positive (Positive) COVID-19 Positive.         For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessment.  Concomitant information not provided. Treatment included nebulizer.  The action taken with mRNA-1273 in response to the event was not applicable.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Oropharyngeal pain, Pain, Pyrexia, SARS-CoV-2 test
Clinical narrative: patient got COVID after getting the vaccine; loss of taste and smell; sore throat; body aches; headaches; fever of 102 F; fatigue; really really stuffy nose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (patient got COVID after getting the vaccine), AGEUSIA (loss of taste and smell), OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (really really stuffy nose) and PAIN (body aches) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced NASAL CONGESTION (really really stuffy nose) and FATIGUE (fatigue). On 14-Mar-2021, the patient experienced COVID-19 (patient got COVID after getting the vaccine), AGEUSIA (loss of taste and smell), OROPHARYNGEAL PAIN (sore throat), PAIN (body aches), HEADACHE (headaches) and PYREXIA (fever of 102 F). The patient was treated with DOXYCYCLINE at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at a dose of 1 UNK; PSEUDOEPHEDRINE HYDROCHLORIDE (PSEUDAFED) at an unspecified dose and frequency; FIBRONECTIN at an unspecified dose and frequency; GUAIFENESIN (MUCINEX) at an unspecified dose and frequency; ASCORBIC ACID (VITAMINS C) at an unspecified dose and frequency; VITAMIN D [VITAMIN D NOS] at an unspecified dose and frequency and ZINC at an unspecified dose and frequency. At the time of the report, COVID-19 (patient got COVID after getting the vaccine), AGEUSIA (loss of taste and smell), OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (really really stuffy nose), PAIN (body aches), HEADACHE (headaches), PYREXIA (fever of 102 F) and FATIGUE (fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Mar-2021, Body temperature: 102 (High) Fever of 102 F. On 14-Mar-2021, SARS-CoV-2 test: positive (Positive) COVID-19 Positive.         For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessment.  Concomitant information not provided. Treatment included nebulizer.  The action taken with mRNA-1273 in response to the event was not applicable.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Headache, Influenza like illness, Pain
Clinical narrative: Diarrhea; Felt flu-like; Body aches; A splitting headache for 1.5 days; Had chills; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), INFLUENZA LIKE ILLNESS (Felt flu-like), PAIN (Body aches), HEADACHE (A splitting headache for 1.5 days) and CHILLS (Had chills) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 011M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced DIARRHOEA (Diarrhea), INFLUENZA LIKE ILLNESS (Felt flu-like), PAIN (Body aches), HEADACHE (A splitting headache for 1.5 days) and CHILLS (Had chills). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (Diarrhea), INFLUENZA LIKE ILLNESS (Felt flu-like), PAIN (Body aches), HEADACHE (A splitting headache for 1.5 days) and CHILLS (Had chills) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not Applicable. Concomitant information not provided.      This case was linked to MOD-2021-053007 (Patient Link).
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site mass, Vaccination site swelling
Clinical narrative: lump at injection site; swelling under arm of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (lump at injection site) and VACCINATION SITE SWELLING (swelling under arm of injection) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced VACCINATION SITE MASS (lump at injection site) and VACCINATION SITE SWELLING (swelling under arm of injection). At the time of the report, VACCINATION SITE MASS (lump at injection site) and VACCINATION SITE SWELLING (swelling under arm of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment information not provided
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Pruritus, Rash, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Heartbeats increased), PRURITUS (itches all over), RASH (Skin rash) and VACCINATION SITE PAIN (Vaccination site tenderness) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. No Medical History information was reported. On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (Heartbeats increased), PRURITUS (itches all over), RASH (Skin rash) and VACCINATION SITE PAIN (Vaccination site tenderness). At the time of the report, HEART RATE INCREASED (Heartbeats increased), PRURITUS (itches all over), RASH (Skin rash) and VACCINATION SITE PAIN (Vaccination site tenderness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant and treatment information not provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pain, Vaccination site swelling
Clinical narrative: hardness at the injection site; redness at the injection site; swelling at the injection site; aching at the injection site/soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (hardness at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site), VACCINATION SITE SWELLING (swelling at the injection site) and VACCINATION SITE PAIN (aching at the injection site/soreness at the injection site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION SITE INDURATION (hardness at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site), VACCINATION SITE SWELLING (swelling at the injection site) and VACCINATION SITE PAIN (aching at the injection site/soreness at the injection site). At the time of the report, VACCINATION SITE INDURATION (hardness at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site), VACCINATION SITE SWELLING (swelling at the injection site) and VACCINATION SITE PAIN (aching at the injection site/soreness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was provided
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 13 days difference between first and second shot; A spontaneous report was received from a consumer concerning a 68-years-old, male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) 2nd dose 13 days after 1st dose/ inappropriate schedule of product administration.  The patient's medical history was not reported. Concomitant product use was not provided by the reporter.   On 09 Mar 2021, prior to the onset of the symptoms, the patient received their first planned doses of mRNA-1273 (Batch number: 031A21A) intramuscularly for the prophylaxis of COVID-19 infection. On 22 Mar 2021, prior to the onset of the symptoms, the patient received their second planned doses of mRNA-1273 (Batch number: 014M20A) intramuscularly for the prophylaxis of COVID-19 infection.  On 22 Mar 2021, the patient received 2nd dose of Moderna vaccination 13 days after 1st dose. Treatment information was not provided  The patient received both scheduled doses of mRNA-1273 prior to the event; therefore, action taken with the drug in response to the event is not applicable.   The outcomes of the event received 2nd dose of Moderna vaccination 13 days after 1st dose was considered resolved on 22 Mar 2021.; Sender's Comments: This report refers to a case of Inappropriate Schedule Of Product Administration for mRNA-1273 (Lot number: 031A21A) with no associated AEs.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Rash macular, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Red blotch; little itchy and pink around the injection site; little itchy and pink around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (little itchy and pink around the injection site), RASH MACULAR (Red blotch) and VACCINATION SITE ERYTHEMA (little itchy and pink around the injection site) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (little itchy and pink around the injection site). On 22-Mar-2021, the patient experienced RASH MACULAR (Red blotch) and VACCINATION SITE ERYTHEMA (little itchy and pink around the injection site). At the time of the report, VACCINATION SITE PRURITUS (little itchy and pink around the injection site), RASH MACULAR (Red blotch) and VACCINATION SITE ERYTHEMA (little itchy and pink around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant and treatment information not provided
Sex: F
Vaccine: COVID19
Symptoms: Ear swelling, Nodule, Pain of skin, Parotitis, Swelling face
Clinical narrative: swelling in her face, earlobe, temple all the way to her head, and had a nodule on the back of her neck, all on the right side; swelling in her face, earlobe, temple all the way to her head, and had a nodule on the back of her neck, all on the right side; swelling in her face, earlobe, temple all the way to her head, and had a nodule on the back of her neck, all on the right side; scalp was tender to the touch; diagnosed with parotitis; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (swelling in her face, earlobe, temple all the way to her head, and had a nodule on the back of her neck, all on the right side), EAR SWELLING (swelling in her face, earlobe, temple all the way to her head, and had a nodule on the back of her neck, all on the right side), NODULE (swelling in her face, earlobe, temple all the way to her head, and had a nodule on the back of her neck, all on the right side), PAIN OF SKIN (scalp was tender to the touch) and PAROTITIS (diagnosed with parotitis) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced SWELLING FACE (swelling in her face, earlobe, temple all the way to her head, and had a nodule on the back of her neck, all on the right side), EAR SWELLING (swelling in her face, earlobe, temple all the way to her head, and had a nodule on the back of her neck, all on the right side), NODULE (swelling in her face, earlobe, temple all the way to her head, and had a nodule on the back of her neck, all on the right side), PAIN OF SKIN (scalp was tender to the touch) and PAROTITIS (diagnosed with parotitis). At the time of the report, SWELLING FACE (swelling in her face, earlobe, temple all the way to her head, and had a nodule on the back of her neck, all on the right side), EAR SWELLING (swelling in her face, earlobe, temple all the way to her head, and had a nodule on the back of her neck, all on the right side), NODULE (swelling in her face, earlobe, temple all the way to her head, and had a nodule on the back of her neck, all on the right side), PAIN OF SKIN (scalp was tender to the touch) and PAROTITIS (diagnosed with parotitis) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medication was reported.  Treatment information was not provided.